Public research summary

TMO Stock Analysis: Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instrument

Data through Sep 8, 2026
Latest close
$675.05
20-day change
+12.41%
Trend state
BULLISH
Classification
Healthcare · Medical - Diagnostics & Research

Market context

Thermo Fisher Scientific Inc moved +12.41% over the latest 20-session window. BullRecon currently classifies the broader setup as BULLISH.

Latest report

The latest cached company filing period (FY2025 · $44.6B revenue · $6.7B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.

Six-dimension read

Quality is currently the strongest dimension at 5.2/6, while Value is the lowest at 3.5/6. Scores are comparative research signals, not forecasts.

Value 3.5/6
Growth 3.6/6
Quality 5.2/6
Profitability 4.7/6
Health 4.7/6
Future 3.7/6
Built from cached market data, company filings and transparent rule-based calculations. Automated research is informational and is not investment advice.

Loading the interactive report and checking your access…